FAM83H Regulates Postnatal T Cell Development Through Thymic Stroma Organization

Read full text
Authors: Betul Melike Ogan, V Forstlová, Laura Jane Dowling, Michaela Simova, Kristína Vičíková, Vendula Novosadová, Frantisek Spoutil, Sylvie Cervenkova, Michaela Procházková, Jolana Turečková, Olha Fedosieieva, Juraj Lábaj
+5 more Petr Nickl, Kamila Křížová, Jan Prochazka, Radislav Sedláček, Jana Balounová
Cited by: 1
References: 33

Abstract

ABSTRACT Family of Sequence Similarity 83H (FAM83H/SACK1H) is primarily expressed in epithelial cells, where it interacts with casein kinase 1 (CK1) and keratins to regulate cytoskeletal organization, cell proliferation, and vesicular trafficking. Mutations in FAM83H are known to cause amelogenesis imperfecta, highlighting its critical role in enamel formation. We generated Fam83h ‐deficient mice ( Fam83h em2(IMPC)Ccpcz , Fam83h −/− ) and mice lacking a part of the N‐terminal CK1‐binding domain ( Fam83h ∆87/∆87 ). Consistent with other Fam83h ‐deficient models, these mice are subviable, smaller in size, and exhibit a sparse, scruffy coat, scaly skin, general weakness, and hypoactivity. Notably, both strains show impaired lymphoid cell development in early postnatal life. In the thymus, Fam83h expression is confined to thymic epithelial cells (TECs), and its deficiency in stromal cells results in disrupted thymic architecture and a severe block in the expansion of double‐negative stage 3 (DN3) T cells, ultimately leading to insufficient T cell production. Single‐cell transcriptomic analysis reveals that Fam83h −/− cortical TECs (cTECs) express reduced levels of the TEC master regulator Foxn1 , and its multiple downstream target genes, suggesting a critical role for FAM83H, likely in coordination with CK1, in cTEC maturation.

Fields of Study & Subjects

Bone and Dental Protein Studies dental development and anomalies TGF-β signaling in diseases

Publication details

Journal / source
European Journal of Immunology
Publisher
Wiley
Volume
56
Issue
1
Pages
e70126–e70126
Publication date
1 January 2026
Language
EN